Keywords: biovision, ag, raises, million, euros, hanover, germany-based
BioVisioN AG raises 15 million euros
Article | 04 February 2002
Hanover, Germany-based biotechnology company BioVisioN has secured itssecond-round financing, raising 15 million euros ($13.3 million), with Heidelberg Innovation as its lead investor. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
